In:
Open Forum Infectious Diseases, Oxford University Press (OUP), Vol. 8, No. 12 ( 2021-12-01)
Abstract:
We compared viral suppression rates between patients who continued tenofovir disoproxil fumarate (TDF)/lamivudine (3TC) vs switched to zidovudine (ZDV)/3TC in combination with a boosted protease inhibitor after failure of first-line efavirenz/TDF/3TC. We found higher rates of viral suppression with continued TDF/3TC compared with switching to ZDV/3TC.
Type of Medium:
Online Resource
ISSN:
2328-8957
DOI:
10.1093/ofid/ofab559
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2021
detail.hit.zdb_id:
2757767-3
Permalink